Scar Treatment Medications in Personal Injury Pharmacy Lien Cases

James Wong — Founder & Pharmacist, LienScripts | March 26, 2026 | 7 min read

Scar treatment medications — silicone gel, corticosteroid injections, laser preparation agents, and topical retinoids — document permanent disfigurement and ongoing treatment needs in personal injury cases. Each refill is evidence of lasting injury for the demand package.

Scar Treatment Medications in Personal Injury Pharmacy Lien Cases

Scar treatment medication in personal injury cases encompasses prescription silicone gel products, intralesional corticosteroid injections (triamcinolone acetonide), topical retinoids, laser preparation and recovery medications, and emerging biologic agents — all prescribed to manage hypertrophic scars, keloids, and contracture scars resulting from traumatic injuries or surgical interventions. For personal injury attorneys, scar treatment prescriptions are uniquely valuable evidence because each refill documents a physician's ongoing clinical finding of permanent disfigurement requiring active medical management.

• Prescription silicone gel sheets and topical silicone gel are the first-line standard of care for hypertrophic scar management, typically applied continuously for 3-12 months
• Intralesional triamcinolone acetonide injections flatten and soften raised scars through corticosteroid-induced collagen remodeling, administered every 4-6 weeks for multiple sessions
• Laser scar revision requires pre-procedure topical anesthetics and post-procedure wound care medications, each session documented in the pharmacy record
• Topical retinoids (tretinoin) and onion extract preparations are prescribed as adjunctive scar therapy for color and texture improvement
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that documents the complete scar treatment medication timeline for demand packages, proving ongoing disfigurement damages

Why Scar Treatment Prescriptions Carry High Evidentiary Value

Scar treatment medications are different from pain medications in a critical way: they treat a visible, permanent condition. According to James Wong, PharmD, founder of LienScripts, "When a treating physician prescribes ongoing scar management for 6, 12, or 18 months, they are documenting — with every refill — that the patient has a permanent physical change from the injury that requires continued medical intervention. That is disfigurement evidence in prescription form."

Disfigurement is a distinct category of general damages in personal injury law. Unlike pain and suffering, which is inherently subjective, disfigurement is visible and verifiable. The scar treatment medication record bridges these two evidence categories — it provides objective pharmaceutical documentation of a visible physical condition.

[!KEY] Every scar treatment prescription refill is a dual piece of evidence: it documents both (1) the existence of permanent disfigurement and (2) the ongoing treatment burden the patient endures because of it. This makes scar medications uniquely powerful in demand packages because they prove two separate damages categories simultaneously.

Silicone-Based Scar Therapy: The Standard of Care

Silicone gel products are the most widely studied and recommended first-line treatment for hypertrophic scars and keloids. International clinical guidelines from the International Advisory Panel on Scar Management recommend silicone as the primary non-invasive scar treatment modality.

Prescription silicone products used in PI cases:

• Silicone gel sheeting — adhesive sheets applied over the scar for 12-24 hours daily, maintaining a hydrated occlusive environment that reduces collagen overproduction. Treatment courses typically last 3-6 months with continuous daily application
• Silicone gel (topical) — self-drying silicone gel applied twice daily to scars, particularly useful for scars in locations where sheeting is impractical (face, hands, joints). Brand names include ScarAway, Kelo-cote, and Dermatix
• Silicone-based scar strips with sustained pressure — used for scars on extremities and trunk where constant gentle pressure enhances silicone therapy

Documentation value: Each silicone product refill documents that the treating physician determined the scar required continued active treatment. A six-month record of continuous silicone gel refills proves the scar has not resolved and remains a clinical concern requiring ongoing management.

Corticosteroid Injections: Treating Raised and Painful Scars

Intralesional corticosteroid injection is the most common in-office procedure for hypertrophic scars and keloids. The medications used for these procedures are dispensed through pharmacies and create prescription records.

Injection agents:

• Triamcinolone acetonide (Kenalog) 10-40 mg/mL — the standard corticosteroid for intralesional scar injection. Injected directly into the scar tissue, it reduces collagen synthesis, softens the scar matrix, and flattens raised tissue. Sessions are typically spaced 4-6 weeks apart, with 3-6 sessions common
• 5-Fluorouracil (5-FU) — an antimetabolite injected alone or in combination with triamcinolone for refractory keloids and hypertrophic scars that do not respond adequately to corticosteroid monotherapy
• Bleomycin — used in tertiary referral settings for highly resistant keloids

[!TIP] Each intralesional injection session generates a pharmacy record for the medication dispensed and a clinical visit record. Cross-referencing the two creates a powerful evidence package: the pharmacy record proves the medication was obtained, and the clinical note documents the scar's clinical appearance at each treatment visit, showing the trajectory of disfigurement over time.

Why corticosteroid injections matter for case value: A series of 4-6 triamcinolone injection sessions documented over 4-6 months establishes that the scar was not a minor cosmetic concern — it was a raised, rigid, or painful hypertrophic scar severe enough to require repeated medical procedures. This documentation directly supports a disfigurement damages claim.

Laser Scar Revision: Medication Components

Laser scar treatment — fractional CO2 laser, pulsed dye laser, or erbium laser — generates pharmacy records for both pre-procedure and post-procedure medications:

Pre-procedure medications:

• Topical lidocaine 4-5% cream (or lidocaine/prilocaine compound) — prescription-strength topical anesthetic applied 30-60 minutes before the procedure
• Valacyclovir (Valtrex) — antiviral prophylaxis prescribed for facial laser procedures to prevent herpes simplex virus reactivation

Post-procedure medications:

• Mupirocin (Bactroban) ointment — topical antibiotic for the treated area
• Topical corticosteroid cream — to manage post-laser inflammation
• Moisturizing barrier creams — prescription-strength healing ointments

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "Laser scar revision is typically performed in a series of 3-5 sessions spaced 4-8 weeks apart. Each session generates a set of pharmacy fills — pre-procedure anesthetic, post-procedure antibiotic, and healing agents. The result is a pharmacy record that documents not just one procedure but an entire course of scar revision treatment."

Adjunctive Scar Medications

Topical retinoids:

• Tretinoin (Retin-A) 0.025-0.05% — promotes collagen remodeling and improves scar texture and pigmentation. Prescribed as a long-term adjunctive therapy alongside silicone products

Antihistamines for scar-related itch:

• Hydroxyzine — for the pruritus that accompanies actively remodeling scars
• Cetirizine or loratadine — daytime antihistamines for persistent scar itch

Topical onion extract (Mederma):

• While available over-the-counter, prescription-strength formulations may be dispensed and documented in the pharmacy record

[!KEY] The total duration of scar treatment is the single most important metric for disfigurement damages. A 12-month scar treatment record — spanning silicone gel, corticosteroid injections, and laser preparation medications — proves that the injury produced permanent physical changes requiring a full year of active medical management. Present this duration prominently in the demand package.

Building the Scar Treatment Demand Package

Organize scar treatment pharmacy records in three categories:

1. Duration evidence — total months of continuous scar treatment prescriptions
2. Escalation evidence — progression from silicone gel to corticosteroid injections to laser revision documents increasing severity or treatment resistance
3. Multi-modality evidence — concurrent use of silicone, injections, and laser medications documents a scar severe enough to require multiple treatment approaches simultaneously

The LienScripts MERIT report compiles the complete scar treatment pharmacy record — every silicone gel refill, every triamcinolone vial, every laser preparation fill — into a chronological, pharmacist-verified document that quantifies the disfigurement treatment burden for the demand package.

Why a Pharmacy Lien Matters for Scar Cases

Scar treatment is expensive and extended. Prescription silicone gel products cost $50-150 per tube, and patients may need monthly refills for 6-12 months. Triamcinolone injection vials, laser preparation medications, and post-procedure agents add additional costs at each treatment session. Without a pharmacy lien, patients frequently discontinue scar treatment due to cost — creating a shorter treatment record that understates the severity of disfigurement.

The LienScripts pharmacy lien covers all scar treatment medications at zero upfront cost, ensuring the patient completes the full recommended treatment course and the attorney has the complete medication record for the demand package.

Related Resources

• Burn Injury Medications: Pain, Infection, and Scar Management
• Burn Injury Medication Management in PI Cases
• Specialty Medications in Personal Injury
• Maximizing Settlement Through Medication Documentation
• What Is a MERIT Report?